Company Snapshot
- Ticker
- BDX
- Name
- BDX
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 56863820800.000000
- Volume
- 2,422,185
- Avg Volume (3M)
- 2,076,462
BDX
BDX
Last update recent
198.40
+9.58
(+5.07%)
Market Cap
56863820800.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 21839000000.000000
- EPS
- 5.84
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 2.1%
- Net Income
- 1678000000.000000
- Net Margin
- 7.68%
- Payout Ratio
- 71.28%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 33.89
- Forward P/E
- None
- P/S
- 2.60
- P/B
- 2.24
- Beta
- None
- Debt / Equity
- 0.76
- Current Ratio
- 1.11
- Return on Equity
- 0.07%
- Return on Assets
- 0.03%
Technicals & Returns
- Distance vs 200 DMA
- 5.24%
- 200 DMA
- 188.53
- Distance vs 50 DMA
- 5.78%
- 50 DMA
- 187.56
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes Read more
- Name
- BDX
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Thomas E. Polen Jr.
- Employees
- 70,000
- IPO Date
- 1973-02-21
- Phone
- 201 847 6800
- Address
- None
- Website
- https://www.bd.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-09-09 • $0.95
Latest News
Curated headlines from premium sources.
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec
FRANKLIN LAKES, N.J. , Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announc…
First Look: IBM nears Confluent deal; Berkshire reshuffle
Stock News China's trade surplus tops $1T YTD: China's exports rose 5.9% in November while imports grew 1.9%, pushing the 11â??month surplus to nearly $1.08 tri
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories
FRANKLIN LAKES, N.J. , Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLO™,…
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
Three- and Four-Laser BD FACSDiscover™ A8 Cell Analyzers Expand Accessibility of Spectral, Real-Time Imaging Cell Analysis FRANKLIN LAKES, N.J. , Dec. 3, 2025 …
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Divide…